p38γ mitogen activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion

被引:43
|
作者
Qi, Xiaomei
Tang, Jun
Loesch, Mathew
Pohl, Nicole
Alkan, Serhan
Chen, Guan
机构
[1] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
[2] Loyola Univ, Dept Radiat Oncol, Maywood, IL 60153 USA
[3] Loyola Univ, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA
[4] Loyola Univ, Dept Pathol, Maywood, IL 60153 USA
[5] Loyola Univ, Program Mol Biol, Maywood, IL 60153 USA
关键词
D O I
10.1158/0008-5472.CAN-05-4639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
W Ras is believed to stimulate invasion and growth by different effector pathways, and yet, the existence of such effectors under physiologic conditions has not been shown. Estrogen receptor (ER), on the other hand, is both anti-invasive and proliferative in human breast cancer, with mechanisms for these paradoxical actions remaining largely unknown. Our previous work showed an essential role of p3Sy mitogen-activated protein kinase in Ras transformation in rat intestinal epithelial cells, and here, we show that p38 gamma integrates invasive antagonism between Ras and ER to increase human breast cancer invasion without affecting their proliferative activity. Ras positively regulates p38,gamma expression, and p38 gamma in turn mediates Ras nonmitogenic signaling to increase invasion. Expression of the Ras/p38 gamma axis, however, is trans-suppressed by ER that inhibits invasion and stimulates growth also by distinct mechanisms. Analysis of ER and its cytoplasmic localized mutant reveals that ER additionally binds to p38 gamma protein, leading to its specific down-regulation in the nuclear compartment. A p38 gamma-antagonistic activity of ER was further shown in a panel of breast cancer cell lines and was shown independent of estrogens by both ER depletion and ER expression. These results revealed that both Ras and ER use distinct pathways to regulate breast cancer growth and invasion, and that p38 gamma specifically integrates their antagonistic activity to stimulate cell invasion. Selective targeting of p3S gamma-dependent invasion pathways may be a novel strategy to control breast cancer progression.
引用
收藏
页码:7540 / 7547
页数:8
相关论文
共 50 条
  • [1] Crosstalk Between Estrogen Receptor and Mitogen-Activated Protein Kinase Signaling in the Development and Progression of Endometrial Cancer
    Zhou, Long
    Cai, Bin
    Bao, Wei
    He, Yin-Yan
    Chen, Xiao-Yue
    Yang, Yi-Xia
    Liu, Xue-Lian
    Wan, Xiao-Ping
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) : 1357 - 1365
  • [2] Formononetin-induced Apoptosis by Activation of Ras/p38 Mitogen-activated Protein Kinase in Estrogen Receptor-positive Human Breast Cancer Cells
    Chen, J.
    Sun, L.
    HORMONE AND METABOLIC RESEARCH, 2012, 44 (13) : 943 - 948
  • [3] Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
    Mao, Lulu
    Yuan, Lin
    Slakey, Lauren M.
    Jones, Frank E.
    Burow, Matthew E.
    Hill, Steven M.
    BREAST CANCER RESEARCH, 2010, 12 (06)
  • [4] Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway
    Lulu Mao
    Lin Yuan
    Lauren M Slakey
    Frank E Jones
    Matthew E Burow
    Steven M Hill
    Breast Cancer Research, 12
  • [5] Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated protein Kinase Activation?
    Cipolla, Gabriel A.
    Park, Jong Kook
    Lavker, Robert M.
    Petzl-Erler, Maria Luiza
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [6] Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
    Gutierrez, MC
    Detre, S
    Johnston, S
    Mohsin, SK
    Shou, JN
    Allred, DC
    Schiff, R
    Osborne, CK
    Dowsett, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) : 2469 - 2476
  • [7] Tumorigenicity of Breast Cancer Cells Lacking the p38 Mitogen-Activated Protein Kinase.
    Mendoza, Rhone A.
    Moody, Emily E.
    Enriquez, Marlene I.
    Mejia, Sylvia M.
    Thordarson, Gudmundur
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [8] p38 mitogen-activated protein kinase and pain
    Mai, Lijia
    Zhu, Xiao
    Huang, Fang
    He, Hongwen
    Fan, Wenguo
    LIFE SCIENCES, 2020, 256
  • [9] The proto-oneoprotein Brx activates estrogen receptor β by a p38 mitogen-activated protein kinase pathway
    Driggers, PH
    Segars, JH
    Rubino, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 46792 - 46797
  • [10] Dissociation of AMP-activated protein kinase and p38 mitogen-activated protein kinase signaling in skeletal muscle
    Ho, Richard C.
    Fujii, Nobuharu
    Witters, Lee A.
    Hirshman, Michael F.
    Goodyear, Laurie J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 362 (02) : 354 - 359